PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.\', \'Division of Molecular Imaging and Therapeutics, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.\', \'Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, LHRB 326, 701 19th Street South, Birmingham, AL, 35294, USA.\', \'Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, LHRB 326, 701 19th Street South, Birmingham, AL, 35294, USA. fadihage@uab.edu.\', \'Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA. fadihage@uab.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00259-020-05123-z
?:hasPublicationType
?:journal
  • European journal of nuclear medicine and molecular imaging
is ?:pmid of
?:pmid
?:pmid
  • 33416952
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.458
?:rankingScore_hIndex
  • 148
?:title
  • Prevalence of abnormal SPECT myocardial perfusion imaging during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all